Gossamer Bio
GOSS
$0.67
Share price
-0.30%
Change (1 day)
-42.91%
Change (1 year)
Categories
Gossamer Bio (GOSS) - Cash on Hand
Cash on Hand as of December 2023 : $0.29 B
According to Gossamer Bio's latest financial reports the company has $0.29 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Gossamer Bio - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.29 B | 15.94% |
| 2022-12-31 | $0.25 B | -21.38% |
| 2021-12-31 | $0.32 B | -36.56% |
| 2020-12-31 | $0.51 B | 27.59% |
| 2019-12-31 | $0.40 B | 75.71% |
| 2018-12-31 | $0.22 B | 72489.84% |
| 2017-12-31 | $0.31 M | 425% |
| 2016-12-31 | $0.06 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -29.77% | 🇺🇸 USA |